Hospital Pharmacy Europe

Hospital Pharmacy Europe Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Hospital Pharmacy Europe, Media/News Company, 1 Giltspur Street, London.

Hospital Pharmacy Europe is a platform for hospital pharmacists to share innovative ideas on how to address their healthcare challenges and ensure they stay up to date with what’s going on in their industry.

Combining genomic data with real-world treatment and outcome data has revealed genetic changes in cancers associated wit...
26/01/2024

Combining genomic data with real-world treatment and outcome data has revealed genetic changes in cancers associated with better or worse survival rates and improved patient outcomes.

Read more about what this might mean for treatment here ⬇️

Combining routine clinical data with whole genome sequence data at scale found to support clinicians in precision cancer care delivery.

The PARP inhibitor has been recommended by to treat a type of locally advanced or metastatic . Read more about the ...
25/01/2024

The PARP inhibitor has been recommended by to treat a type of locally advanced or metastatic .

Read more about the recommendation here 🔽

The PARP inhibitor talazoparib has been recommended by NICE to treat a type of locally advanced or metastatic breast cancer.

Fluoroquinolone antibiotics must only be administered when other recommended antibiotics ‘have failed, will not work due...
25/01/2024

Fluoroquinolone antibiotics must only be administered when other recommended antibiotics ‘have failed, will not work due to resistance, or are unsafe to use in an individual patient’.

Read more about the MHRA's latest drug safety update here ⬇️

Fluoroquinolone antibiotics should only be prescribed when ‘no other antibiotics are appropriate for use’, says MHRA drug safety update.

A consultation on draft standards setting out the professional responsibilities of a in the UK has been launched by th...
24/01/2024

A consultation on draft standards setting out the professional responsibilities of a in the UK has been launched by the GPhC to support the delivery of safe and effective pharmacy services.

Read more about the proposed standards here 🔽

A consultation on draft standards setting out the professional responsibilities of a chief pharmacist has been launched by the GPhC.

Subcutaneous has been granted marketing authorisation by the European Commission for multiple types.Find out more ab...
19/01/2024

Subcutaneous has been granted marketing authorisation by the European Commission for multiple types.

Find out more about the approval here ⬇️

Subcutaneous atezolizumab has been granted marketing authorisation by the European Commission for multiple cancer types.

Patients with cardiomyopathy are often prescribed the same medication as those with myocardial infarction despite it n...
19/01/2024

Patients with cardiomyopathy are often prescribed the same medication as those with myocardial infarction despite it not improving outcomes, according to a new study.

Find out more here 🔽

Heart treatments given to patients with takotsubo cardiomyopathy do not protect them, according to a new comparative study.

A new Technology Appraisal has recommended that can be prescribed as an add-on to standard care in .Click here to r...
18/01/2024

A new Technology Appraisal has recommended that can be prescribed as an add-on to standard care in .

Click here to read more 🔽

NICE has recommended that empagliflozin can be used as an add-on option for treating CKD in adults under some circumstances.

The EMA and MHRA are considering new evidence suggesting that children whose fathers took during the three months befo...
18/01/2024

The EMA and MHRA are considering new evidence suggesting that children whose fathers took during the three months before conception are at increased risk of .

Find out more here ⤵️

The UK and European medicines regulators are considering new evidence linking paternal valproate use before conception to child autism risk.

Foslevodopa-foscarbidopa has been launched in the for the treatment of advanced disease.Find out more about this fir...
17/01/2024

Foslevodopa-foscarbidopa has been launched in the for the treatment of advanced disease.

Find out more about this first-of-its-kind subcutaneous treatment here 🔽

The subcutaneous drug foslevodopa-foscarbidopa has been launched in the EU for the treatment of advanced Parkinson’s disease.

A number of grants from Pharmacy Research UK are now open for application from and , including full funding for a ful...
17/01/2024

A number of grants from Pharmacy Research UK are now open for application from and , including full funding for a full-time studentship and various research projects.

Click here to read more ⬇️

A number of grants from Pharmacy Research UK (PRUK) are now open for application, including full funding for a full-time PhD studentship.

Pharmacists have an important role to play in fluid management, but a recent report concluded that there are significant...
16/01/2024

Pharmacists have an important role to play in fluid management, but a recent report concluded that there are significant gaps in education and training on the subject.

Click here to read Manu Malbrain's take on implementing effective fluid stewardship ⤵️

Healthcare institutions should implement programmes on fluid stewardship to achieve their quality improvement and patient safety goals.

Did you see our in-depth interview with London North West University Healthcare NHS Trust's team?They embarked on a ...
10/01/2024

Did you see our in-depth interview with London North West University Healthcare NHS Trust's team?

They embarked on a pilot that has changed the face of their practice for the better.

Read about their project and progress here ⤵️

London North West University Healthcare NHS Trust's person-centred care pilot has changed the face of their pharmacy practice for the better.

The 'Pharmacy Matters' pledge from the RPS is encouraging prospective parliamentary candidates to ensure is part of he...
10/01/2024

The 'Pharmacy Matters' pledge from the RPS is encouraging prospective parliamentary candidates to ensure is part of health service debates ahead of the next UK .

Find out more about this and the Society's other election priorities here ⬇️

The RPS has called on pharmacists across the UK to help ensure pharmacy is part of health service debates ahead of the next general election.

The European Commission has approved the antimycotic for the treatment of in adults.Find out more here 🔽
09/01/2024

The European Commission has approved the antimycotic for the treatment of in adults.

Find out more here 🔽

Rezafungin has been approved by the European Commission for the treatment of invasive candidiasis in adults.

NHS England’s workforce group for is seeking to recruit five new pharmacist or pharmacy technician members.Find out ...
09/01/2024

NHS England’s workforce group for is seeking to recruit five new pharmacist or pharmacy technician members.

Find out more here ⬇️

NHS England’s pharmacy workforce group for genomics is seeking to recruit five new pharmacist or pharmacy technician members.

'Involving pharmacists in the multidisciplinary management of older patients with cancer seems essential,' says Chloé He...
08/01/2024

'Involving pharmacists in the multidisciplinary management of older patients with cancer seems essential,' says Chloé Herledan.

Here, the pharmacist shares an overview of a recent position paper on the importance of collaboration in .

Read more ⤵️

Pharmacist Chloé Herledan shares an overview of a new position paper on the collaborative management of older patients with cancer.

The supply of GLP-1 receptor agonists is not expected to return to normal until at least the end of 2024, the UK Governm...
08/01/2024

The supply of GLP-1 receptor agonists is not expected to return to normal until at least the end of 2024, the UK Government has confirmed.



Read more here 🔽

The supply of GLP-1 RAs is not expected to return to normal until at least the end of 2024, the UK Government has confirmed.

Is drinkable insulin really on the horizon for diabetes?Here, professor of pharmaceutics Afzal R Mohammed looks to the f...
05/01/2024

Is drinkable insulin really on the horizon for diabetes?

Here, professor of pharmaceutics Afzal R Mohammed looks to the future and shares his insights on emerging innovations in .

Click to find out more ⤵️ https://bit.ly/48pdoEU

Professor Afzal R Mohammed shares his perspective on the challenges and promising advances in biologics and the future of drug delivery.

Address

1 Giltspur Street
London
EC1A9DD

Website

Alerts

Be the first to know and let us send you an email when Hospital Pharmacy Europe posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Videos

Use of colchicine associated with reduced risk of hip and knee replacement (HPE) (2).mp4
Use of colchicine associated with reduced risk of hip and knee replacement (HPE) (2).mp4

In an exploratory analysis of low-dose colchicine use to reduce the occurrence of cardiovascular events, researchers have discovered that the drug decreases the incidence of hip and knee replacements for osteoarthritis. Read the full story here ⬇️ https://bit.ly/3PbqGOF

NICE recommends extending dapagliflozin use in heart failure to reduce hospitalisations (HPE) Update.mp4
NICE recommends extending dapagliflozin use in heart failure to reduce hospitalisations (HPE) Update.mp4

NICE has recommended that dapagliflozin be extended as a treatment option for symptomatic chronic heart failure in patients with preserved or mildly reduced ejection fraction. View the full story https://bit.ly/3qcE1vv

Cannabidiol reduces anxiety and improves cognition
Cannabidiol reduces anxiety and improves cognition

Find out how full spectrum cannabidiol reduces anxiety and improves cognition according to a small study: https://bit.ly/3TpGRYs

Shortcuts

Share

Category